{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T04:27:36Z","timestamp":1721363256001},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"4","funder":[{"name":"LEO Pharma"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s13555-015-0087-0","type":"journal-article","created":{"date-parts":[[2015,11,5]],"date-time":"2015-11-05T09:40:42Z","timestamp":1446716442000},"page":"235-246","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["An Applicator Delivery System for Fixed-Combination Calcipotriene Plus Betamethasone Dipropionate Topical Suspension (Gel): Innovating Psoriasis Vulgaris Treatment Through Patient Collaboration"],"prefix":"10.1007","volume":"5","author":[{"given":"Gritt","family":"Rasmussen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lene Lillevang","family":"Bech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torben Wager","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,11,5]]},"reference":[{"key":"87_CR1","unstructured":"World Health Organization. Adherence to long-term therapies. Evidence for action. 2003. http:\/\/whqlibdoc.who.int\/publications\/2003\/9241545992.pdf ."},{"key":"87_CR2","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","volume":"353","author":"L Osterberg","year":"2005","unstructured":"Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487\u201397.","journal-title":"N Engl J Med"},{"key":"87_CR3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/bjd.12039","volume":"168","author":"RJ Thorneloe","year":"2013","unstructured":"Thorneloe RJ, Bundy C, Griffiths CE, et al. Adherence to medication in patients with psoriasis: a systematic literature review. Br J Dermatol. 2013;168:20\u201331.","journal-title":"Br J Dermatol"},{"key":"87_CR4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1477-7525-4-35","volume":"4","author":"MJ Bhosle","year":"2006","unstructured":"Bhosle MJ, Kulkarni A, Feldman SR, et al. Quality of life in patients with psoriasis. Health Qual Life Outcomes. 2006;4:35.","journal-title":"Health Qual Life Outcomes"},{"key":"87_CR5","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/jid.2012.339","volume":"133","author":"R Parisi","year":"2013","unstructured":"Parisi R, Symmons DP, Griffiths CE, et al. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol. 2013;133:377\u201385.","journal-title":"J Invest Dermatol"},{"key":"87_CR6","unstructured":"World Health Organization. Psoriasis: Sixty seventh World Health Assembly Agenda item 13. 5. 2014. http:\/\/apps.who.int\/gb\/ebwha\/pdf_files\/WHA67\/A67_R9-en.pdf . Accessed 19 Oct 2015."},{"key":"87_CR7","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.jaad.2008.12.032","volume":"60","author":"A Menter","year":"2009","unstructured":"Menter A, Korman NJ, Elmets CA, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis section\u00a03. Guidelines of care for the management and treatment of psoriasis with topical therapies. J Am Acad Dermatol. 2009;60:643\u201359.","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 4","key":"87_CR8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1468-3083.2011.04060.x","volume":"25","author":"A Bewley","year":"2011","unstructured":"Bewley A, Page B. Maximizing patient adherence for optimal outcomes in psoriasis. J Eur Acad Dermatol Venereol. 2011;25(Suppl 4):9\u201314.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"Suppl 3","key":"87_CR9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1468-3083.2012.04525.x","volume":"26","author":"S Devaux","year":"2012","unstructured":"Devaux S, Castela A, Archier E, et al. Adherence to topical treatment in psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol. 2012;26(Suppl 3):61\u20137.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"87_CR10","first-page":"92","volume":"12","author":"A Menter","year":"2013","unstructured":"Menter A, Stein Gold L, Bukhalo M, et al. Calcipotriene plus betamethasone dipropionate topical suspension for the treatment of mild to moderate psoriasis vulgaris on the body: a randomized, double-blind, vehicle-controlled trial. J Drugs Dermatol. 2013;12:92\u20138.","journal-title":"J Drugs Dermatol"},{"key":"87_CR11","first-page":"1156","volume":"26","author":"K Reich","year":"2014","unstructured":"Reich K, Zschocke I, Bachelez H, et al. Efficacy of a fixed combination of calcipotriol\/betamethasone dipropionate topical gel in adult patients with mild to moderate psoriasis: blinded interim analysis of a phase IV, multicenter, randomized, controlled, prospective study. J Eur Acad Dermatol Venereol. 2014;26:1156\u201363.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"87_CR12","doi-asserted-by":"crossref","unstructured":"Lambert J, Griekspoor M, Vink J. Patient-reported effectiveness for calcipotriol and betamethasone dipropionate gel and ointment formulations in psoriasis vulgaris: 4- and 12-week interim results from PRO-long. 22nd Congress of the European Academy of Dermatology and Venereology (EADV). Istanbul, Turkey; 2\u20136 Oct 2013; abst P1590.","DOI":"10.1111\/jdv.12387"},{"key":"87_CR13","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1111\/jdv.12387","volume":"28","author":"J Lambert","year":"2014","unstructured":"Lambert J, Hol CW, Vink J. Real-life effectiveness of once-daily calcipotriol and betamethasone dipropionate gel vs. ointment formulations in psoriasis vulgaris: 4- and 12-week interim results from the PRO-long study. J Eur Acad Dermatol Venereol. 2014;28:1723\u201331.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"87_CR14","doi-asserted-by":"crossref","first-page":"775","DOI":"10.2147\/PPA.S61248","volume":"8","author":"RL Hall","year":"2014","unstructured":"Hall RL, Willgoss T, Humphrey LJ, et al. The effect of medical device dose-memory functions on patients\u2019 adherence to treatment, confidence, and disease self-management. Patient Prefer Adherence. 2014;8:775\u201388.","journal-title":"Patient Prefer Adherence"},{"key":"87_CR15","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/j.amjmed.2014.07.006","volume":"127","author":"C Sorli","year":"2014","unstructured":"Sorli C. New developments in insulin therapy for type 2 diabetes. Am J Med. 2014;127:S39\u201348.","journal-title":"Am J Med"},{"key":"87_CR16","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/jdv.12174","volume":"28","author":"A Bewley","year":"2013","unstructured":"Bewley A, Burrage DM, Ersser SJ, et al. Identifying individual psychosocial and adherence support needs in patients with psoriasis: a multinational two-stage qualitative and quantitative study. J Eur Acad Dermatol Venereol. 2013;28:763\u201370.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"87_CR17","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2165\/00128071-200506060-00005","volume":"6","author":"AB Kimball","year":"2005","unstructured":"Kimball AB, Jacobson C, Weiss S, et al. The psychosocial burden of psoriasis. Am J Clin Dermatol. 2005;6:383\u201392.","journal-title":"Am J Clin Dermatol"},{"key":"87_CR18","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1477-7525-7-62","volume":"7","author":"D Globe","year":"2009","unstructured":"Globe D, Bayliss MS, Harrison DJ. The impact of itch symptoms in psoriasis: results from physician interviews and patient focus groups. Health Qual Life Outcomes. 2009;7:62.","journal-title":"Health Qual Life Outcomes"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-015-0087-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T08:28:20Z","timestamp":1567326500000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13555-015-0087-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,5]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["87"],"URL":"https:\/\/doi.org\/10.1007\/s13555-015-0087-0","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,5]]}}}